Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Puberty
100%
Tumor Growth
100%
Neurofibromatosis Type I
100%
Neurofibromatosis Type 1 (NF-1)
100%
Plexiform Neurofibroma
100%
Peripubertal
50%
Estradiol
33%
Tumor Volume
33%
National Institutes of Health
16%
Cardiac Magnetic Resonance Imaging (cMRI)
16%
Growth Rate
16%
Chemotherapy
16%
Growth Factors
16%
Pediatric
16%
Insulin-like
16%
Male Patients
16%
Progesterone
16%
Testosterone
16%
Follicle-stimulating Hormone
16%
Tumor Burden
16%
Luteinizing Hormone
16%
Young Adult Patients
16%
Group-based
16%
Hormonal Changes
16%
Design Analysis
16%
Tanner Stage
16%
Pubertal Changes
16%
Detection Software
16%
Tumor Growth Rate
16%
Patient Weight
16%
Lesion Detection
16%
Pubertal Progression
16%
Testosterone Change
16%
Image Detection
16%
Statistically Significant Difference
16%
Nursing and Health Professions
Tumor Growth
100%
Neurofibromatosis
100%
Neurofibroma
100%
Tumor Volume
75%
Diethylstilbestrol
50%
Testosterone
50%
Neurofibromatosis Type 1
50%
National Health Organization
25%
Nuclear Magnetic Resonance Imaging
25%
Progesterone
25%
Somatomedin C
25%
Follitropin
25%
Luteinizing Hormone
25%
Pediatrics
25%
Chemotherapy
25%
Medicine and Dentistry
Tumor Progression
100%
Plexiform Neurofibroma
100%
Neurofibromatosis
100%
Neoplasm
75%
Diethylstilbestrol
50%
Neurofibromatosis Type I
50%
Testosterone
50%
Magnetic Resonance Imaging
25%
Pediatrics
25%
Follitropin
25%
Progesterone
25%
Somatomedin C
25%
Luteinizing Hormone
25%
Chemotherapy
25%